Design of a novel chimeric multi-epitope vaccine construct against Staphylococcus lugdunensis using pan-genome analysis and immunoinformatics approaches
Abstract
Staphylococcus lugdunensis has emerged as an increasingly important opportunistic pathogen associated with invasive infections and rising antimicrobial resistance, creating a need for new preventive approaches. In this study, a reverse-vaccinology strategy integrated with immunoinformatics analyses was applied to genomic datasets derived from 29 complete genomes. Pan-genome evaluation identified 1689 conserved core proteins, from which four surface-associated proteins were prioritized as potential vaccine targets based on their predicted antigenic properties and favorable safety profiles. Predicted epitopes derived from these proteins were assembled into a multi-epitope vaccine construct. Computational assessment predicted broad global population coverage of 99.47% of the selected epitopes used for multi-epitope vaccine design together with favorable physicochemical properties, including predicted solubility and a low instability index of 15.54. Molecular docking analyses predicted favorable interactions between the vaccine construct and TLR2 and TLR4. Furthermore, 100 ns molecular dynamics simulations suggested that the receptor–vaccine complexes maintained overall conformational stability throughout the simulation period. Computational immune simulations predicted adaptive immune responses characterized by antibody production, cellular immune responses, and immunological memory formation. Collectively, these computational findings suggest that the proposed multi-epitope vaccine construct represents a promising candidate for further experimental validation as a potential preventive strategy against S. lugdunensis .
Related
- Integrated immunoinformatics and molecular dynamics approaches reveal a promising multi-epitope vaccine against hantavirus
- Immunoinformatics design and in vitro evaluation of dendritic cell-targeting brucellosis multi-epitope vaccine based on Omp28 and GroEL
- Computational designing of multiepitope based vaccine (MEBV) candidate against human metapneumovirus (HMPV) using immunoinformatics approach
- Integrative Machine Learning and Immunoinformatics-Guided Design and In Silico Validation of a Multiepitope DNA Vaccine Against Avian Metapneumovirus.
- Design of a tetravalent dengue vaccine incorporating T-cell epitopes from NS3 and NS5 proteins and B-cell epitopes from the envelope protein using an immunoinformatics approach.
BibTeX
@article{aljohani2026design,
title = {{Design of a novel chimeric multi-epitope vaccine construct against Staphylococcus lugdunensis using pan-genome analysis and immunoinformatics approaches}},
author = {Waad A. Aljohani},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-70190-5},
url = {https://www.nature.com/articles/s41598-026-70190-5},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Design of a novel chimeric multi-epitope vaccine construct against Staphylococcus lugdunensis using pan-genome analysis and immunoinformatics approaches
AU - Waad A. Aljohani
PY - 2026
DA - 2026/10/05
JO - Scientific Reports
DO - 10.1038/s41598-026-70190-5
UR - https://www.nature.com/articles/s41598-026-70190-5
AB - Staphylococcus lugdunensis has emerged as an increasingly important opportunistic pathogen associated with invasive infections and rising antimicrobial resistance, creating a need for new preventive approaches. In this study, a reverse-vaccinology strategy integrated with immunoinformatics analyses was applied to genomic datasets derived from 29 complete genomes. Pan-genome evaluation identified 1689 conserved core proteins, from which four surface-associated proteins were prioritized as potential vaccine targets based on their predicted antigenic properties and favorable safety profiles. Predicted epitopes derived from these proteins were assembled into a multi-epitope vaccine construct. Computational assessment predicted broad global population coverage of 99.47% of the selected epitopes used for multi-epitope vaccine design together with favorable physicochemical properties, including predicted solubility and a low instability index of 15.54. Molecular docking analyses predicted favorable interactions between the vaccine construct and TLR2 and TLR4. Furthermore, 100 ns molecular dynamics simulations suggested that the receptor–vaccine complexes maintained overall conformational stability throughout the simulation period. Computational immune simulations predicted adaptive immune responses characterized by antibody production, cellular immune responses, and immunological memory formation. Collectively, these computational findings suggest that the proposed multi-epitope vaccine construct represents a promising candidate for further experimental validation as a potential preventive strategy against S. lugdunensis .
SN - 2045-2322
ER -